Cryo-Cell - 31 Year Stock Price History | CCEL
Historical daily share price chart and data for Cryo-Cell since 1994 adjusted for splits and dividends. The latest closing stock price for Cryo-Cell as of June 20, 2025 is 5.13.
- The all-time high Cryo-Cell stock closing price was 11.36 on September 02, 2021.
- The Cryo-Cell 52-week high stock price is 9.43, which is 83.8% above the current share price.
- The Cryo-Cell 52-week low stock price is 4.75, which is 7.4% below the current share price.
- The average Cryo-Cell stock price for the last 52 weeks is 6.81.
| Cryo-Cell Historical Annual Stock Price Data | ||||||
|---|---|---|---|---|---|---|
| Year | Average Stock Price | Year Open | Year High | Year Low | Year Close | Annual % Change |
| 2025 | 6.0921 | 6.9416 | 8.0891 | 4.6723 | 5.1300 | -26.40% |
| 2024 | 6.5141 | 5.2992 | 8.5701 | 4.4404 | 6.9698 | 32.67% |
| 2023 | 4.5104 | 3.9653 | 6.4322 | 2.7136 | 5.2535 | 35.93% |
| 2022 | 5.5149 | 9.3042 | 9.4967 | 3.7643 | 3.8648 | -58.46% |
| 2021 | 8.1684 | 5.9515 | 11.3575 | 5.9515 | 9.3042 | 50.65% |
| 2020 | 5.9396 | 5.7830 | 7.6599 | 4.4115 | 6.1761 | 7.99% |
| 2019 | 6.0921 | 5.6547 | 7.1386 | 5.1334 | 5.7189 | -4.93% |
| 2018 | 6.4965 | 7.5717 | 7.9808 | 4.8366 | 6.0156 | -22.44% |
| 2017 | 4.9650 | 3.4570 | 7.7562 | 3.4490 | 7.7562 | 112.06% |
| 2016 | 2.8826 | 2.5667 | 3.6575 | 2.2057 | 3.6575 | 42.50% |
| 2015 | 2.3034 | 1.9651 | 2.8073 | 1.7004 | 2.5667 | 30.61% |
| 2014 | 2.0662 | 1.4758 | 2.6549 | 1.4598 | 1.9651 | 32.43% |
| 2013 | 1.6447 | 1.6202 | 1.8849 | 1.4438 | 1.4839 | -11.90% |
| 2012 | 1.7892 | 1.6844 | 2.0614 | 1.4438 | 1.6844 | 5.00% |
| 2011 | 1.9236 | 1.9250 | 2.9437 | 1.2432 | 1.6042 | -16.66% |
| 2010 | 1.1631 | 1.2432 | 1.9651 | 0.6898 | 1.9250 | 34.83% |
| 2009 | 1.0896 | 0.3369 | 1.8608 | 0.3369 | 1.4277 | 323.78% |
| 2008 | 0.5629 | 0.6818 | 0.7620 | 0.3208 | 0.3369 | -46.83% |
| 2007 | 1.4887 | 1.7887 | 1.9812 | 0.6336 | 0.6336 | -65.35% |
| 2006 | 2.2065 | 2.6950 | 3.0880 | 1.7566 | 1.8288 | -32.94% |
| 2005 | 2.5860 | 3.6014 | 5.3740 | 1.7245 | 2.7271 | -20.93% |
| 2004 | 1.3758 | 0.6176 | 3.5372 | 0.4813 | 3.4490 | 458.45% |
| 2003 | 0.7389 | 1.3315 | 1.4037 | 0.3850 | 0.6176 | -52.76% |
| 2002 | 2.7465 | 4.0666 | 4.7885 | 1.2352 | 1.3074 | -66.73% |
| 2001 | 4.4192 | 1.8548 | 8.2294 | 1.7546 | 3.9302 | 111.89% |
| 2000 | 4.4899 | 6.0156 | 9.6250 | 1.7044 | 1.8548 | -68.10% |
| 1999 | 3.0596 | 2.3561 | 6.4167 | 1.2031 | 5.8151 | 152.17% |
| 1998 | 1.8968 | 2.5065 | 3.3086 | 0.4261 | 2.3060 | -8.00% |
| 1997 | 3.3951 | 2.8073 | 5.4141 | 2.4063 | 2.5065 | -7.41% |
| 1996 | 3.3427 | 1.8047 | 5.1634 | 1.4037 | 2.7070 | 125.00% |
| 1995 | 2.8967 | 1.6042 | 5.4141 | 0.5013 | 1.2031 | -25.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.041B | $0.032B |
| CRYO-CELL International is engaged in cryogenic cellular storage and the design and developmentof cellular storage devices. They currently focus on the processing and preservation of umbilical cord blood stem cells for autologous/sibling use. They have pioneered several technologies that allow for the processing and storage of specimens in a cryogenic environment, and presently, their mission of affordability for U-Cord blood preservation remains in effect. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $140.550B | 26.36 |
| Elevance Health (ELV) | United States | $84.617B | 10.92 |
| CVS Health (CVS) | United States | $84.212B | 10.47 |
| Cencora (COR) | United States | $56.918B | 19.80 |
| Natera (NTRA) | United States | $23.467B | 0.00 |
| DiDi Global (DIDIY) | China | $22.356B | 23.75 |
| Labcorp Holdings (LH) | United States | $21.919B | 17.78 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.557B | 0.00 |
| Solventum (SOLV) | United States | $12.729B | 13.47 |
| CochLear (CHEOY) | Australia | $12.142B | 0.00 |
| ICON (ICLR) | Ireland | $11.829B | 11.00 |
| Revvity (RVTY) | United States | $11.196B | 19.27 |
| Doximity (DOCS) | United States | $10.774B | 49.88 |
| Viatris (VTRS) | United States | $10.411B | 3.58 |
| Avantor (AVTR) | United States | $9.247B | 13.44 |
| Medpace Holdings (MEDP) | United States | $8.892B | 23.62 |
| HealthEquity (HQY) | United States | $8.760B | 38.37 |
| Sonic Healthcare (SKHHY) | Australia | $8.172B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.242B | 14.19 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.149B | 24.44 |
| BrightSpring Health Services (BTSG) | United States | $3.915B | 35.92 |
| Sotera Health (SHC) | United States | $3.233B | 18.37 |
| Alignment Healthcare (ALHC) | United States | $2.762B | 0.00 |
| Concentras Parent (CON) | United States | $2.658B | 15.36 |
| Organon (OGN) | United States | $2.535B | 2.69 |
| Surgery Partners (SGRY) | United States | $2.473B | 32.17 |
| PACS (PACS) | United States | $2.009B | 0.00 |
| GeneDx Holdings (WGS) | United States | $1.912B | 73.63 |
| Ardent Health (ARDT) | United States | $1.865B | 7.95 |
| Premier (PINC) | United States | $1.816B | 13.79 |
| Progyny (PGNY) | United States | $1.798B | 39.58 |
| GoodRx Holdings (GDRX) | United States | $1.643B | 32.86 |
| Teladoc Health (TDOC) | United States | $1.211B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.136B | 8.64 |
| Establishment Labs Holdings (ESTA) | $1.093B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.56 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.999B | 0.00 |
| Agilon Health (AGL) | United States | $0.873B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.839B | 7.85 |
| QDM (QDMI) | Hong Kong, SAR China | $0.729B | 0.00 |
| LifeMD (LFMD) | United States | $0.671B | 0.00 |
| Nutex Health (NUTX) | United States | $0.633B | 9.58 |
| Embecta (EMBC) | United States | $0.571B | 3.85 |
| InnovAge Holding (INNV) | United States | $0.525B | 0.00 |
| Enhabit (EHAB) | United States | $0.469B | 38.63 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 10.35 |
| Sonida Senior Living (SNDA) | United States | $0.452B | 0.00 |
| SBC Medicals (SBC) | United States | $0.447B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.433B | 0.00 |
| Omada Health (OMDA) | $0.391B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.269B | 0.00 |
| Oncology Institute (TOI) | United States | $0.213B | 0.00 |
| Beauty Health (SKIN) | United States | $0.203B | 0.00 |
| DocGo (DCGO) | United States | $0.162B | 26.50 |
| Pheton Holdings (PTHL) | China | $0.128B | 0.00 |
| So-Young (SY) | China | $0.119B | 0.00 |
| KindlyMD (NAKA) | United States | $0.086B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.072B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.045B | 0.00 |
| Biodesix (BDSX) | United States | $0.038B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.033B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.012B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.004B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |